DBV Technologies S.A. DBVT on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001613780
0001613780
EIN:
LEI:
(CF Office: 03 Life Sciences)
Business address:
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France, 92320
Phone: 33(0)155427878
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France, 92320
Phone: 33(0)155427878
Mailing address:
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France, 92320
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France, 92320
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Filings:
480 EDGAR filings since July 25, 2014
480 EDGAR filings since July 25, 2014
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 8, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- December 18, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- December 16, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing
Selected Filings
[+] 8-K (current reports)
- March 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- January 8, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- December 18, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- December 16, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing
- December 11, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- November 6, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- July 30, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 7, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 26, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- April 8, 2024 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- January 31, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- December 5, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- November 27, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 432 of 480 entries
Data source:
CIK0001613780.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
